These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

573 related articles for article (PubMed ID: 23856551)

  • 1. [Treatment of Dupuytren's contracture by collagenase injection].
    Foissac R; Camuzard O; Dumas P; Dumontier C; Chignon-Sicard B
    Chir Main; 2013 Sep; 32(4):199-205. PubMed ID: 23856551
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Collagenase Clostridum histolyticum in the management of Dupuytren's contracture].
    Holzer LA; Holzer G
    Handchir Mikrochir Plast Chir; 2011 Oct; 43(5):269-74. PubMed ID: 21935843
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Injectable collagenase clostridium histolyticum for Dupuytren's contracture.
    Hurst LC; Badalamente MA; Hentz VR; Hotchkiss RN; Kaplan FT; Meals RA; Smith TM; Rodzvilla J;
    N Engl J Med; 2009 Sep; 361(10):968-79. PubMed ID: 19726771
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Injectable collagenase Clostridium histolyticum: a new nonsurgical treatment for Dupuytren's disease.
    Gilpin D; Coleman S; Hall S; Houston A; Karrasch J; Jones N
    J Hand Surg Am; 2010 Dec; 35(12):2027-38.e1. PubMed ID: 21134613
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Collagenase clostridium histolyticum injection for the treatment of Dupuytren's contracture.
    Kaplan FT
    Drugs Today (Barc); 2011 Sep; 47(9):653-67. PubMed ID: 21971540
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Injectable collagenase clostridium histolyticum for Dupuytren's contracture.
    Holzer LA; Holzer G
    N Engl J Med; 2009 Dec; 361(26):2579; author reply 2579-80. PubMed ID: 20050321
    [No Abstract]   [Full Text] [Related]  

  • 7. ▾Xiapex for Dupuytren's contracture.
    Drug Ther Bull; 2011 Dec; 49(12):138-41. PubMed ID: 22170410
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Dupuytren's disease treatment].
    Kornø MR; Søe N; Dahlin LB
    Ugeskr Laeger; 2015 Mar; 177(11):. PubMed ID: 25786701
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Collagenase clostridium histolyticum in Dupuytren's contracture: a systematic review.
    Smeraglia F; Del Buono A; Maffulli N
    Br Med Bull; 2016 Jun; 118(1):149-58. PubMed ID: 27151958
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Collagenase clostridium histolyticum for Dupuytren's contracture.
    Desai SS; Hentz VR
    Expert Opin Biol Ther; 2010 Sep; 10(9):1395-404. PubMed ID: 20666587
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clostridium histolyticum collagenase in the treatment of Dupuytren's contracture.
    Azzopardi E; Boyce DE
    Br J Hosp Med (Lond); 2012 Aug; 73(8):432-6. PubMed ID: 22875519
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Injectable collagenase clostridium histolyticum for Dupuytren's contracture.
    Zhang P; Qin L
    N Engl J Med; 2009 Dec; 361(26):2578-9; author reply 2579-80. PubMed ID: 20032329
    [No Abstract]   [Full Text] [Related]  

  • 13. Efficacy and safety of collagenase clostridium histolyticum injection for Dupuytren contracture: short-term results from 2 open-label studies.
    Witthaut J; Jones G; Skrepnik N; Kushner H; Houston A; Lindau TR
    J Hand Surg Am; 2013 Jan; 38(1):2-11. PubMed ID: 23218556
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of Treatment Outcomes after Collagenase Injection and Percutaneous Needle Fasciotomy for Dupuytren's Contracture: Objective and Subjective Comparisons with a 3-Year Follow-Up.
    Abe Y
    Plast Reconstr Surg; 2020 Jun; 145(6):1464-1474. PubMed ID: 32459776
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and safety of collagenase Clostridium histolyticum injection for Dupuytren contracture: report of 40 cases.
    Alberton F; Corain M; Garofano A; Pangallo L; Valore A; Zanella V; Adani R
    Musculoskelet Surg; 2014 Dec; 98(3):225-32. PubMed ID: 24254968
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and safety of collagenase treatment for Dupuytren's disease: 2-year follow-up results.
    Van Beeck A; Van den Broek M; Michielsen M; Didden K; Vuylsteke K; Verstreken F
    Hand Surg Rehabil; 2017 Oct; 36(5):346-349. PubMed ID: 28732844
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New treatment option for Dupuytren's contracture.
    Mayo Clin Health Lett; 2010 Oct; 28(10):4. PubMed ID: 21033070
    [No Abstract]   [Full Text] [Related]  

  • 18. Efficacy and safety of collagenase clostridium histolyticum in the treatment of proximal interphalangeal joints in dupuytren contracture: combined analysis of 4 phase 3 clinical trials.
    Badalamente MA; Hurst LC; Benhaim P; Cohen BM
    J Hand Surg Am; 2015 May; 40(5):975-83. PubMed ID: 25843533
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cost Comparison of Collagenase Clostridium Histolyticum and Fasciectomy for Treatment of Dupuytren's Contracture in the Australian Health System.
    Sefton AK; Smith BJ; Stewart DA
    J Hand Surg Asian Pac Vol; 2018 Sep; 23(3):336-341. PubMed ID: 30282551
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DupuytrEn Treatment EffeCtiveness Trial (DETECT): a protocol for prospective, randomised, controlled, outcome assessor-blinded, three-armed parallel 1:1:1, multicentre trial comparing the effectiveness and cost of collagenase clostridium histolyticum, percutaneous needle fasciotomy and limited fasciectomy as short-term and long-term treatment strategies in Dupuytren's contracture.
    Räisänen MP; Karjalainen T; Göransson H; Reito A; Kautiainen H; Malmivaara A; Leppänen OV
    BMJ Open; 2018 Mar; 8(3):e019054. PubMed ID: 29599391
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.